文献速递脊柱关节炎

中轴型脊柱关节炎疾病活动度解读需考虑中枢敏化、疾病感知与肥胖

Central sensitization, illness perception and obesity should be considered when interpreting disease activity in axial spondyloarthritis.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

该研究纳入182例长病程中轴型脊柱关节炎门诊患者,评估中枢敏化、疾病感知与肥胖同疾病活动度评分的关系。结果显示中枢敏化、疾病感知部分维度及肥胖独立关联ASDASCRP与BASDAI,仅肥胖独立关联CRP。提示解读患者报告的活动度评分时需考虑这些因素。

要点

  • 45%患者CSI≥40提示中枢敏化可能常见
  • 中枢敏化、疾病感知与肥胖独立关联ASDASCRP和BASDAI
  • 仅肥胖独立关联CRP

核心结论

  • 中枢敏化可能在中轴型脊柱关节炎长病程患者中常见。
  • 中枢敏化、特定疾病感知及肥胖均独立关联ASDASCRP与BASDAI。
  • 仅肥胖独立关联CRP。

研究设计与样本

  • 纳入Groningen Leeuwarden中轴型脊柱关节炎(GLAS)队列连续门诊患者182例。
  • 患者完成中枢敏化量表(CSI)、疾病感知问卷(IPQ-R)与疼痛灾难化量表(PCS)。
  • 采用单变量与多变量线性回归分析问卷评分、患者特征与ASDASCRP、BASDAI及CRP的关联。

主要发现

  • 患者平均症状持续时间21.6年,平均ASDASCRP为2.1,平均BASDAI为3.9,CRP中位数2.9。
  • 平均CSI评分为37.8(量表0-100),45%患者CSI≥40提示中枢敏化高概率。
  • CSI评分、IPQ-R身份维度、IPQ-R治疗控制维度及肥胖独立关联ASDASCRP与BASDAI,分别解释R²=0.35与R²=0.47的变异。
  • 仅肥胖独立关联CRP。

关键数值与推荐

  • CSI评分≥40提示中枢敏化高概率,45%患者达到该阈值。
  • 中枢敏化、疾病感知与肥胖对ASDASCRP变异的解释度为R²=0.35,对BASDAI为R²=0.47。

临床怎么用

  • 随访与治疗中解读ASDASCRP和BASDAI时,应考虑中枢敏化、疾病感知与肥胖的影响。
  • 对患者报告活动度评分持续偏高者,可评估中枢敏化与肥胖等混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Many patients with axial spondyloarthritis (axSpA) report persistent pain even when treated with anti-inflammatory agents. Our aim was to explore the presence of central sensitization (CS) and different types of illness perceptions in patients with axSpA, and to assess their associations with disease activity assessments. METHODS: Consecutive outpatients from the Groningen Leeuwarden Axial Spondyloarthritis (GLAS) cohort were included. Besides standardized assessments, patients filled out the Central Sensitization Inventory (CSI), Illness Perception Questionnaire (IPQ-R) and Pain Catastrophizing Scale (PCS). Univariable and multivariable linear regression analyses were used to investigate the association between questionnaire scores, patient characteristics and disease activity assessments ASDASCRP, BASDAI and CRP. RESULTS: We included 182 patients with a mean symptom duration of 21.6 years. Mean ASDASCRP was 2.1, mean BASDAI 3.9, and median CRP 2.9. Mean CSI score was 37.8 (scale 0-100) and 45% of patients scored ≥40, indicating a high probability of CS. CSI score, IPQ-R domain identity (number of symptoms the patient attributes to their illness), and IPQ-R domain treatment control (perceived treatment efficacy), and obesity were significantly and independently associated with both ASDASCRP and BASDAI, explaining a substantial proportion of variation in these disease activity scores (R2=0.35 and R2=0.47, respectively). Only obesity was also independently associated with CRP. CONCLUSION: CS may be common in patients with long-term axSpA. CS, as well as specific illness perceptions and obesity were all independently associated with the widely used (partially) patient-reported disease activity assessments ASDASCRP and BASDAI. Treating physicians should take this into account in the follow-up and treatment of their patients.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Kieskamp SC, Paap D, Carbo MJG, et al. Central sensitization, illness perception and obesity should be considered when interpreting disease activity in axial spondyloarthritis. Rheumatology (Oxford). 2021. PMID: 33492397. doi:10.1093/rheumatology/keab019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。